Form 4: Kindly MD CCO Acquires 601,503 Restricted Stock Units

Kindly MD's Chief Commercial Officer, Andrew John Creighton, acquired 601,503 restricted stock units with a four-year vesting schedule.

Summary

• Andrew John Creighton, Chief Commercial Officer of Kindly MD, Inc. (NAKA), acquired 601,503 shares of Common Stock in the form of Restricted Stock Units (RSUs).
• The transaction date for this acquisition was September 22, 2025.
• The RSUs were acquired at a price of $0 per share.
• Following this transaction, Andrew John Creighton beneficially owns 3,726,474 shares.
• The RSUs will time-vest over a four-year period.
• There will be no vesting during the first twelve months following August 15, 2025 (the 'Cliff Period').
• Twenty-five percent (25%) of the RSUs will vest upon completion of the Cliff Period.
• The remaining seventy-five percent (75%) of the RSUs will vest in equal quarterly installments over the subsequent thirty-six months.
• Vesting is subject to Andrew John Creighton's continued service to Kindly MD, Inc. through each applicable vesting date.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a key executive is generally a positive signal, indicating long-term commitment and alignment of interests between management and shareholders. It is a standard compensation practice and not indicative of immediate financial performance, but rather future incentive.

Positives

• The grant of Restricted Stock Units (RSUs) aligns the Chief Commercial Officer's long-term interests with those of the shareholders.
• Increased insider ownership demonstrates a commitment from a key executive to the company's future performance.

Negatives

• The RSUs have no immediate cash value for the recipient, as they are subject to a multi-year vesting schedule.
• The vesting is contingent on continued service, meaning the executive must remain employed to realize the full benefit.

Risks

• The reporting person risks forfeiture of unvested Restricted Stock Units if their service to the issuer ceases before the vesting conditions are met.

Future Outlook

The vesting schedule for the Restricted Stock Units indicates a long-term incentive structure designed to retain the Chief Commercial Officer and align their performance with the company's future success over a four-year period.

Industry Context

This RSU grant is a standard form of executive compensation in the public company landscape, aiming to incentivize long-term performance and retention. It reflects a common practice for aligning executive interests with shareholder value creation.

Comparison to Industry Standards

• The four-year vesting schedule with a one-year cliff period is a common structure for executive equity compensation, aligning with typical industry practices for long-term incentive plans across various sectors.
• The grant of RSUs at a $0 price is standard for compensatory equity awards, reflecting their nature as a performance or retention incentive rather than a direct purchase.

Stakeholder Impact

• Shareholders: The RSU grant aligns the Chief Commercial Officer's financial interests with long-term shareholder value creation, potentially leading to more focused strategic decisions.
• Employees: This type of executive compensation can set a precedent for performance-based incentives within the company, potentially influencing broader compensation strategies.

Next Steps

• The Chief Commercial Officer will continue to provide service to Kindly MD, Inc. to meet the vesting conditions for the Restricted Stock Units.
• The RSUs will begin to vest after the twelve-month Cliff Period following August 15, 2025, with 25% vesting at that point.
• The remaining 75% of the RSUs will vest in equal quarterly installments over the subsequent 36 months.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event (RSU grant) which, while positive for aligning management incentives with shareholder interests, does not provide new fundamental information that would warrant a change in investment recommendation. It reinforces a 'hold' stance due to the long-term commitment shown by the executive.

Keywords

Kindly MD, NAKA, Restricted Stock Units, RSUs, Insider Transaction, Executive Compensation, Form 4, Equity Grant, Vesting Schedule, Chief Commercial Officer